Document Finishing by Wordzworth
Document Finishing by Wordzworth
Document Finishing by Wordzworth
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
www.mpbio.com<br />
CATALOG<br />
NUMBER<br />
CYCLOHEXIMIDE READY MADE<br />
Antibiotic solution<br />
Concentration: Approx. 100 mg/ml in DMSO (0.2 um filtered),<br />
microbial solution.<br />
Cycloheximide is an antibiotic product. Its main biological activity is<br />
translation inhibition in eukaryotes. The resulting inhibition of protein<br />
synthesis leads to cell growth arrest and death. Cycloheximide is<br />
used for selection of Cycloheximide resistant yeast and fungi strains,<br />
controlled inhibition systhesis for detection of short-lived proteins and<br />
superinduction of protein apoptosis induction or facilitation of apoptosis<br />
induction <strong>by</strong> death receptors.<br />
0 TO 5°C 66-81-9<br />
199520 1 ml<br />
N 6 -CYCLOHEXYLADENOSINE<br />
(CHA)<br />
C16H23N5O4<br />
RT MW 349.4 36396-99-3<br />
153748 10 mg<br />
CYCLOHEXYLAMINE<br />
Free Base<br />
Purity: 98-99%<br />
1 ml = 0.87 g<br />
C6H13N<br />
RT MW 99.2 108-91-8<br />
150745<br />
25 ml<br />
N-CYCLOHEXYLMALEIMIDE<br />
Crystalline<br />
RT 1631-25-0<br />
101461 5 g<br />
1,6-bis-(CYCLOHEXYLOXIMINO-<br />
CARBONYLAMINO)-HEXANE<br />
(RHC-80267)<br />
Purity: 98%<br />
Specifically blocks diacylglycerol (DAG) lipase activity in various cell<br />
lines of multiple species.<br />
Ref.: 1. Balsinde, J., et al., J. Biol. Chem., 266: 15638 (1991). 2.<br />
Southerland, C.A. and Amin, D., et al., ibid., 257: 14006 (1982). 3.<br />
Lindlisbacher, B., et al., J. Neurochem., 54: 1247 (1990). 4. Natarajan,<br />
R., et al., Biochem. Biophys. Res. Commun., 156: 171 (1988).<br />
RT MW 394.6<br />
159011 10 mg<br />
CYCLO(HIS-PHE)<br />
C15H16N4O2<br />
-20 TO 0°C MW 284.3 56586-95-9<br />
153085 5 mg<br />
CYCLOPENTANE<br />
Purity: 97%<br />
1 ml = approx. 0.75 g<br />
C5H10<br />
0 TO 5°C MW 70.1 287-92-3<br />
150747 100 ml<br />
500 ml<br />
Biochemicals<br />
Alphabetical List<br />
CATALOG<br />
NUMBER<br />
CYCLOPENTANONE<br />
Purity: 99+%<br />
1 ml = approx. 0.95 g<br />
C5H8O<br />
RT MW 84.1 120-92-3<br />
150748 50 ml<br />
500 ml<br />
8-CYCLOPENTYL-1,3-DIMETHYLXANTHINE<br />
(8-Cyclopentyltheophylline)<br />
A1 adenosine receptor antagonist.<br />
C12H16N4O2<br />
RT MW 248.3 35873-49-5<br />
153746<br />
8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE<br />
(DPCPX, 1,3-Dipropyl-8-cyclopentylxanthine)<br />
A1 adenosine receptor antagonist.<br />
C16H24N4O2<br />
RT MW 305.4 102146-07-6<br />
153745<br />
25 mg<br />
CYCLOPHILIN A<br />
(Peptidylproline cis-trans-isomerase)<br />
Human, Recombinant<br />
Purity: >90%<br />
Expressed in E. coli and supplied in 20 mM Tris-HCl, pH 7.8.<br />
Accelerates protein folding <strong>by</strong> catalyzing the cis-trans-isomeration of<br />
x-pro-peptide bonds. Will bind to cyclosporins.<br />
Ref.: 1. Kunz, J. and Hall, M.M., Trends in Biochem. Sci., 18: 334<br />
(1993).<br />
2. Fruman, D.A., et al., FASEB J., 8: 391 (1994).<br />
0 TO 5°C MW ~18,000 95076-93-0<br />
159910 100 µg<br />
CYCLOPHOSPHAMIDE<br />
Monohydrate<br />
Purity: 98+%<br />
Cancer research tool.<br />
C7H15Cl2N2O2P • H2O<br />
0°C MW 336.4 18172-33-3<br />
158895<br />
25 mg<br />
0 TO 5°C MW 279.1 6055-19-2<br />
150749 1 g<br />
5 g<br />
10 g<br />
25 g<br />
CYCLOPIAZONIC ACID<br />
From: Penicillium species<br />
Purity: 98%<br />
Intracellular Ca 2+ release inducer. Inhibits endoplasmic reticulum Ca 2+ -<br />
ATPase. Highly selective for sarcoplasmic reticulum Ca 2+ -ATPase.<br />
Ref.: 1. Demaurex, N., et al., J. Biol. Chem., 267: 2318 (1992). 2.<br />
Goeger, D.E., et al., Biochem. Pharmacol., 37: 978 (1988). 3. Seidler,<br />
N.W., et al., J. Biol. Chem., 264: 17816 (1989).<br />
C20H20N2O3<br />
5 mg<br />
10 mg<br />
50 mg<br />
www.mpbio.com To place an order 1.800.854.0530, fax 1.800.334.6999<br />
165
Change language